Group 1 - The article discusses the impact of U.S. tariffs on China, highlighting that these measures are increasingly ineffective and may harm the U.S. itself [1] - China has tightened its export controls on rare earth elements, which are crucial for various industries, including high-tech and military, putting pressure on the U.S. [3] - Following Trump's announcement of new tariffs, the U.S. stock market reacted negatively, indicating the potential economic repercussions of such policies [5] Group 2 - A report from The New York Times reveals that nearly half of the raw materials for over 700 imported drugs in the U.S. come from China, emphasizing the dependency of the U.S. pharmaceutical industry on Chinese supplies [7] - If China were to impose similar restrictions on pharmaceutical raw materials as it did with rare earths, it could severely disrupt the U.S. drug industry [9] - The U.S. pharmaceutical sector has largely outsourced raw material production to countries like China due to high domestic production costs, which are significantly higher than those in China [11] Group 3 - The instability of Indian pharmaceutical products makes U.S. companies prefer sourcing from China, despite the potential for increased costs due to tariffs [13] - The U.S. government has previously delayed imposing tariffs on pharmaceuticals due to backlash from domestic drug companies concerned about rising drug prices [15] - The article highlights the critical nature of certain drugs, such as "cisplatin," which are essential for cancer treatment, underscoring the potential health risks associated with supply disruptions [15] Group 4 - The ongoing trade tensions have led to a situation where U.S. companies face significant challenges, as China's countermeasures target key sectors like technology and agriculture [17] - The article suggests that the U.S. government's attempts to impose tariffs have resulted in a complex situation where both sides experience pain, but the impact on U.S. consumers and businesses is more immediate [19] - Ultimately, the article argues that the trade conflict may necessitate a return to negotiations, as tariffs alone cannot resolve the underlying issues [19]
美媒急眼:别惹中国!稀土之后医药原料再成王牌,直击美国命门!
Sou Hu Cai Jing·2025-10-20 15:11